|
Marché Fermé -
Nasdaq
22:00:00 09/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 12,31 USD | -7,09% |
|
-11,82% | +135,37% |
| 11/08 | Immix Biopharma, Inc. : Morgan Stanley reste à l'achat | ZM |
| 07/08 | Immix Biopharma, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026 | CI |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -7,09% | -11,82% | +26,65% | +53,68% | +135,37% | +439,91% | +371,65% | - | - | 948 M | |
| -0,94% | -0,71% | +0,04% | +65,68% | +70,87% | +45,60% | +103,25% | +10,02% | - | 69,19 Md | |
| -0,07% | -3,93% | +13,36% | +14,14% | +20,70% | +32,54% | +78,50% | +205,72% | +5 887,54% | 62,97 Md | |
| +3,13% | +1,71% | -1,75% | +30,05% | -25,99% | -12,50% | +390,48% | +357,71% | +877,24% | 27,27 Md | |
| -0,54% | -5,47% | +4,76% | +13,45% | +3,08% | -3,88% | -18,31% | -72,07% | - | 24,78 Md | |
| -0,66% | -4,69% | +4,77% | +62,69% | +53,69% | +28,51% | +13,16% | -59,26% | - | 25,8 Md | |
| -1,43% | -1,89% | +6,75% | +32,51% | +5,28% | +21,32% | -19,01% | -25,36% | +113,40% | 20,11 Md | |
| -4,27% | +3,07% | +8,47% | +50,70% | +217,44% | +211,22% | +362,48% | +1 697,71% | +830,17% | 18,47 Md | |
| -1,00% | -4,51% | -10,24% | +18,19% | +20,96% | -5,21% | +507,43% | - | - | 14,88 Md | |
| +1,14% | -0,34% | +7,88% | +10,08% | +33,08% | +52,38% | +163,82% | +198,52% | +386,89% | 14,29 Md | |
| +1,50% | +20,14% | +25,64% | +22,74% | +0,29% | -6,83% | +1 038,96% | +166,16% | +183,82% | 13,79 Md | |
| +2,34% | -0,05% | +7,18% | +14,63% | -6,13% | +21,82% | +178,09% | +582,39% | +4 838,21% | 12,34 Md | |
| -2,91% | -3,21% | -5,73% | +12,68% | +24,46% | +197,98% | +176,35% | +26,56% | +1 054,05% | 12,02 Md | |
| +0,68% | +5,29% | -5,81% | +8,70% | -15,40% | -28,39% | +159,43% | +117,27% | - | 11,3 Md | |
| -1,65% | +3,03% | -3,45% | +8,27% | +16,64% | +43,90% | +105,52% | +146,62% | +715,29% | 10,48 Md | |
| -1,41% | -3,36% | +2,48% | +26,94% | +28,98% | +81,88% | +17,42% | +128,97% | - | 8,98 Md | |
| -2,77% | +1,38% | +5,50% | +11,17% | +307,07% | +213,62% | +524,81% | -18,99% | - | 8,79 Md | |
| -1,55% | -6,53% | -10,44% | +8,43% | +5,42% | -25,15% | +101,06% | -27,85% | - | 8,54 Md | |
| -4,25% | -0,14% | -17,14% | +13,72% | +165,35% | +419,30% | +520,93% | -51,03% | -49,97% | 8,01 Md | |
| -5,02% | +14,00% | +12,33% | +29,51% | +14,50% | +178,87% | +481,28% | - | - | 7,77 Md | |
| Moyenne | -1,33% | +2,36% | +3,56% | +25,40% | +53,78% | +95,34% | +262,86% | +199,01% | +1 483,66% | 19,04 Md | |
| Moyenne pondérée par Capi. | -0,66% | +0,87% | +4,01% | +31,11% | +43,76% | +54,52% | +195,06% | +186,99% | +2 502,36% |
- Bourse
- Actions
- Action IMMX
- Secteur Immix Biopharma, Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
